The Role of [

68Ga-prostate-specific membrane antigen PET/CT PSMA clinically significant cancer mpMRI primary diagnosis prostate cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Oct 2022
Historique:
received: 14 09 2022
revised: 04 10 2022
accepted: 10 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

The purpose of the study is to systematically evaluate the evidence regarding the role of [

Identifiants

pubmed: 36291820
pii: cancers14205036
doi: 10.3390/cancers14205036
pmc: PMC9600353
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4252-4261
pubmed: 34773473
Int Urol Nephrol. 2007;39(1):189-95
pubmed: 16835725
Indian J Nucl Med. 2021 Oct-Dec;36(4):377-384
pubmed: 35125755
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Nucl Med Commun. 2018 Nov;39(11):1013-1021
pubmed: 30216228
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):908-920
pubmed: 30635755
Indian J Urol. 2019 Jul-Sep;35(3):202-207
pubmed: 31367071
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859-873
pubmed: 32901351
AJR Am J Roentgenol. 2021 Mar;216(3):607
pubmed: 32812791
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):477-482
pubmed: 32696091
Curr Opin Urol. 2018 Nov;28(6):493-498
pubmed: 30188333
Clin Transl Oncol. 2021 Jan;23(1):172-178
pubmed: 32447644
BJU Int. 2019 Nov;124 Suppl 1:42-49
pubmed: 31287613
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):20-30
pubmed: 30229528
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Eur Urol. 2020 Sep;78(3):402-414
pubmed: 32444265
Eur Urol. 2015 Mar;67(3):569-76
pubmed: 25257029
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Abdom Radiol (NY). 2018 Jul;43(7):1787-1797
pubmed: 29177924
Int J Comput Assist Radiol Surg. 2015 Dec;10(12):1997-2007
pubmed: 26054983
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
J Nucl Med. 2019 Jul;60(7):944-949
pubmed: 30552201
Lancet Oncol. 2019 Jan;20(1):100-109
pubmed: 30470502
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Urol. 2018 Jul;200(1):95-103
pubmed: 29409824
Eur Urol Focus. 2019 Jul;5(4):592-599
pubmed: 29226826
Eur Urol. 2021 Mar;79(3):413-418
pubmed: 33341285
Prostate Cancer Prostatic Dis. 2018 Jun;21(2):204-211
pubmed: 29858591
Eur Urol. 2021 Dec;80(6):682-689
pubmed: 34465492
Prostate Int. 2022 Jun;10(2):108-116
pubmed: 35510079
Cent European J Urol. 2021;74(3):315-320
pubmed: 34729219
Eur Urol. 2022 Apr;81(4):337-346
pubmed: 34980492
Medicine (Baltimore). 2020 Sep 4;99(36):e20755
pubmed: 32898989
J Cancer Res Clin Oncol. 2022 Jun;148(6):1299-1311
pubmed: 35217902
Sci Rep. 2020 Jul 3;10(1):10963
pubmed: 32620790
Eur Urol Oncol. 2022 Oct;5(5):601-602
pubmed: 35835637
Quant Imaging Med Surg. 2022 Jan;12(1):53-65
pubmed: 34993060
Cancer Imaging. 2020 Jan 23;20(1):10
pubmed: 31973751
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):483-492
pubmed: 32734457
Urol Case Rep. 2017 Jun 03;14:11-14
pubmed: 28607878
Radiology. 2017 Oct;285(1):147-156
pubmed: 28582632
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
J Urol. 2020 Jun;203(6):1122-1127
pubmed: 31868556
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Eur Urol. 2015 Jul;68(1):8-19
pubmed: 25454618
Eur Urol Open Sci. 2020 Jul;20:37-47
pubmed: 33000006
Theranostics. 2021 Jul 25;11(17):8396-8411
pubmed: 34373749
Radiology. 2018 May;287(2):725-726
pubmed: 29668418
Pathol Oncol Res. 2009 Jun;15(2):167-72
pubmed: 18802790
J Nucl Med. 2019 Oct;60(10):1350-1358
pubmed: 31481573
Prostate Int. 2020 Mar;8(1):10-15
pubmed: 32257972
World J Surg. 2006 Apr;30(4):628-36
pubmed: 16555021
Cancers (Basel). 2022 Jul 19;14(14):
pubmed: 35884558
Indian J Nucl Med. 2020 Oct-Dec;35(4):283-290
pubmed: 33642751
Eur Urol Focus. 2021 Jul;7(4):764-771
pubmed: 32312701
PLoS One. 2022 Feb 3;17(2):e0263345
pubmed: 35113918
BJU Int. 2020 Jul;126(1):83-90
pubmed: 31260602
J Nucl Med. 2020 Sep;61(9):1314-1319
pubmed: 32034111
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4042-4053
pubmed: 34386839
Oncotarget. 2017 Nov 14;8(67):111073-111083
pubmed: 29340038
J Clin Oncol. 2015 Jan 20;33(3):272-7
pubmed: 25512465
Diagnostics (Basel). 2021 Mar 19;11(3):
pubmed: 33808825
Value Health Reg Issues. 2022 Jul;30:31-38
pubmed: 35042021
BMJ. 2020 Aug 14;370:m2632
pubmed: 32816740
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95
pubmed: 23179945

Auteurs

Matteo Caracciolo (M)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.

Angelo Castello (A)

Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Luca Urso (L)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Francesca Borgia (F)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Naima Ortolan (N)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Licia Uccelli (L)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Corrado Cittanti (C)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.

Massimo Castellani (M)

Nuclear Medicine Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Mirco Bartolomei (M)

Nuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.

Massimo Lazzeri (M)

Department of Urology, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.

Egesta Lopci (E)

Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Italy.

Classifications MeSH